Testing MOUD Scale-Up Strategies in Criminal Legal Settings
This three-arm cluster randomized trial will assess how best to expand medications for opioid use disorder (MOUD) in 120 prisons across 12 states. It compares two scalable, cost-effective implementation strategiesโpolicy levers and multisite learning collaborativesโboth borrowed from successful approaches used in low-resourcesettings. The study is motivated by strong evidence for MOUD, persistently low access in prisons, major health inequities among incarcerated people, and the high risk of overdose during reentry to the community.
Study Aims
Principal Investigator
Todd Molfenter, PhD
University of Wisconsin
MPI
Rosemarie Martin, PhD
University of Massachusetts Chan Medical School
Co-Investigators
- Faye S. Taxman, PhD, George Mason University
- Ali Jalali, PhD, Cornell University
Justice Agency Partner
- Kevin Kemp, Correctional Leaders Association